Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial updates for an investigational monoclonal antibody therapy in patients with hormone-refractory prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Investigational monoclonal antibody therapy (name not disclosed)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED